#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • A Study of Cizutamig for Patients with Severe Autoimmune Inflammatory Diseases That Did Not Respond to Previous Treatments

    Recruiting

    1 1 1
    Investigated Diseases:
    Germany

  • A Study of Idecabtagene Vicleucel CAR-T Cell Therapy for Patients with Autoimmune Diseases That Did Not Respond to B Cell Removal Treatment

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • A long-term safety study of KYV-101 in patients previously treated for lupus nephritis, systemic sclerosis, myasthenia gravis, rheumatoid arthritis, or stiff person syndrome

    Recruiting

    4 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • A Study Testing Anti-CD19 CAR T-Cell Therapy in Patients with Systemic Sclerosis Who Did Not Respond to Immunosuppressive Drugs

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study of AlloNK and rituximab with cyclophosphamide and fludarabine in adults with relapsing rheumatoid arthritis, inflammatory myopathies, systemic sclerosis, or Sjögren’s disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria France Germany Italy Poland Portugal +2

  • Study of Blinatumomab Treatment in Patients with Systemic Lupus Erythematosus, Systemic Sclerosis, or Granulomatosis with Polyangiitis: Safety and Effectiveness Evaluation

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Study on the Effects and Safety of Rituximab and Sodium Chloride in Patients with Active Systemic Sclerosis

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study on the Safety of CNTY-101 and Aldesleukin for Patients with Active Autoimmune Diseases: Lupus, Scleroderma, and Myositis

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Study on the Effectiveness and Safety of Efgartigimod PH20 SC for Adults with Systemic Sclerosis

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria Croatia Czechia Denmark France +10

  • Study on the Safety of T-Guard (Dafsolimab Setaritox, Grisnilimab Setaritox) for Patients with Early Diffuse Cutaneous Systemic Sclerosis

    Recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands